Press Release

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source...

SEOUL, SOUTH KOREA, September 8, 2026 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the 2026 World Conference on Lung Cancer (WCLC 2026), to...

Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/...

Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today...

Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a...

Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a...